Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Mercaptopropionic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.42 |
| ▸ | ANPEP | P15144 | 4/20 | 0.40 |
| ▸ | ENPEP | Q07075 | 4/20 | 0.40 |
| ▸ | GABRP | O00591 | 2/20 | 0.39 |
| ▸ | GABRD | O14764 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.39 |
| ▸ | GABRE | P78334 | 2/20 | 0.39 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.39 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.39 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mercaptopropionic Acid SCHEMBL29687079 | 1.00 | TDP1 (0.48) | TDP1ACEFOLH1ANPEPENPEP | |
| Mercaptopropionic Acid SCHEMBL2127412 | 1.00 | TDP1 (0.48) | TDP1ACEFOLH1ANPEPENPEP | |
| Mercaptopropionic Acid SCHEMBL16738048 | 0.88 | ACE (0.48) | ACEFOLH1ANPEPENPEPGABRP | |
| Mercaptopropionic Acid SCHEMBL28858261 | 0.87 | ACE (0.52) | ACEFOLH1ANPEPENPEPGABRP | |
| Propylene Glycol SCHEMBL3086361 | 0.86 | FOLH1 (0.56) | TDP1FOLH1ENPEPLMNA | |
| Mercaptopropionic Acid SCHEMBL18423364 | 0.85 | ACE (0.50) | ACEFOLH1ANPEPENPEPGABRP | |
| Succinic Acid SCHEMBL1134610 | 0.85 | TDP1 (0.59) | TDP1GABRPGABRDGABRA1GABRB1 | |
| Succinic Acid SCHEMBL29364481 | 0.85 | TDP1 (0.59) | TDP1GABRPGABRDGABRA1GABRB1 | |
| 1,3-Butanediol SCHEMBL15379530 | 0.85 | GABRP (0.45) | ACEFOLH1ANPEPENPEPGABRP | |
| Mercaptopropionic Acid SCHEMBL538146 | 0.83 | ACE (0.48) | ACEFOLH1ANPEPENPEPLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3158012-B1 | FIRE-RESISTANT COMPOUND AND ITS UTILISATION | HILTI AG (LI) | 2020-02-19 | — | — | EP | claimed |
| US-10392516-B2 | Fire protection composition and use thereof | HILTI AKTIENGESELLSCHAFT (LI) | 2019-08-27 | — | — | US | claimed |
| US-10287504-B2 | Composition that forms an insulating layer and use thereof | HILTI AKTIENGESELLSCHAFT (LI) | 2019-05-14 | — | — | US | claimed |
| US-10000659-B2 | Insulating layer-forming composition and use thereof | HILTI AKTIENGESELLSCHAFT (LI) | 2018-06-19 | — | — | US | claimed |
| EP-2935475-B1 | INSULATING LAYER-FORMING COMPOSITION AND USE THEREOF | HILTI AG (LI) | 2017-07-19 | — | — | EP | claimed |
| US-20170145223-A1 | Fireproof Composition and Use Thereof | HILTI AKTIENGESELLSCHAFT (LI) | 2017-05-25 | — | — | US | claimed |
| US-20170130066-A1 | Fire Protection Composition and Use Thereof | HILTI AKTIENGESELLSCHAFT (LI) | 2017-05-11 | — | — | US | claimed |
| US-20150337160-A1 | INSULATING LAYER-FORMING COMPOSITION AND THE USE THEREOF | HILTI AKTIENGESELLSCHAFT (LI) | 2015-11-26 | — | — | US | claimed |
| US-20150299578-A1 | COMPOSITION THAT FORMS AN INSULATING LAYER AND USE THEREOF | HILTI AKTIENGESELLSCHAFT (LI) | 2015-10-22 | — | — | US | claimed |
| US-20150275031-A1 | INSULATING LAYER-FORMING COMPOSITION AND USE THEREOF | HILTI AKTIENGESELLSCHAFT (LI) | 2015-10-01 | — | — | US | claimed |
| US-12624279-B2 | Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4703778-A1 | WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE | Dai Nippon Printing Co., Ltd. (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-12565548-B2 | Compound, polymerizable composition, and cured product | FUJIFILM CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-4202505-B1 | BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE IN WHICH SAME IS USED, AS WELL AS METHOD FOR SELECTING BARRIER FILM | DAINIPPON PRINTING CO LTD (JP) | 2026-02-18 | — | — | EP | disclosed |
| EP-4667546-A1 | PHOTOCURABLE COMPOSITION | Bostik SA (FR) | 2025-12-24 | — | — | EP | disclosed |
| EP-2055726-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Showa Denko K.K. (JP) | 2009-05-06 | — | — | EP | disclosed |
| US-4536523-A | Dental composite formulation from acrylate monomer and polythiol accelerator | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 1985-08-20 | — | — | US | disclosed |
| US-RE30810-E | HEAT STABILIZERS FOR POLYMERS | THIOKOL CORPORATION (US) | 1981-12-01 | — | — | US | disclosed |
| US-RE30032-E | POLYMER STABILIZERS | CINCINNATI MILACRON CHEMICALS, INC. (US) | 1979-06-12 | — | — | US | disclosed |
| US-3979359-A | STABILIZERS FOR VINYL- AND VINYLIDENE HALIDE POLYMERS | CINCINNATI MILACRON CHEMICALS, INC. (US) | 1976-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624279-B2 | Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device | NLRP1, NLRP3, ALAD | TDP1 3439/4885ACE 3176/4885FOLH1 3567/4885 |
| US-12565548-B2 | Compound, polymerizable composition, and cured product | SEM1, PSMA1, RER1 | TDP1 1808/4885ACE 4668/4885FOLH1 3624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.